FDA Cites Able For Failing To Reject Out-Of-Specification Drugs, Altering Data
• By The Pink Sheet
Able Labs routinely failed to reject drugs that did not meet established standards, specifications and quality control criteria, according to FDA inspectional observations included in a "Form 483" report
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
